Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:dateCreated |
1975-12-4
|
| pubmed:language |
srp
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0065-1214
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
20
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
337-42
|
| pubmed:dateRevised |
2009-11-9
|
| pubmed:meshHeading |
pubmed-meshheading:4219358-Amniotic Fluid,
pubmed-meshheading:4219358-Bilirubin,
pubmed-meshheading:4219358-Delivery, Obstetric,
pubmed-meshheading:4219358-Erythroblastosis, Fetal,
pubmed-meshheading:4219358-Female,
pubmed-meshheading:4219358-Humans,
pubmed-meshheading:4219358-Pregnancy,
pubmed-meshheading:4219358-Rh-Hr Blood-Group System
|
| pubmed:year |
1974
|
| pubmed:articleTitle |
[Bilirubin level in the amniotic fluid as an indicator in the management of the delivery in RH sensitized pregnancy].
|
| pubmed:publicationType |
Journal Article,
English Abstract
|